Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
NCT07697040
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG:
Becotatug Vedotin Combined with Cisplatin and Concurrent Radiotherapy
Sponsor
Hebei Medical University Fourth Hospital